Cargando…

Optimizing and Individualizing the Pharmacological Treatment of First-Episode Schizophrenic Patients: Study Protocol for a Multicenter Clinical Trial

Introduction: Affecting ~1% of the world population, schizophrenia is known as one of the costliest and most burdensome diseases worldwide. Antipsychotic medications are the main treatment for schizophrenia to control psychotic symptoms and efficiently prevent new crises. However, due to poor compli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Jingmei, Huang, Jing, Long, Yujun, Wang, Xiaoyi, Wang, Ying, Yang, Ye, Hei, Gangrui, Sun, Mengxi, Zhao, Jin, Li, Li, Shao, Tiannan, Wang, Weiyan, Kang, Dongyu, Liu, Chenchen, Xie, Peng, Huang, Yuyan, Wu, Renrong, Zhao, Jingping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947302/ https://www.ncbi.nlm.nih.gov/pubmed/33716817 http://dx.doi.org/10.3389/fpsyt.2021.611070

Ejemplares similares

Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials
por: Kang, Dongyu, et al.
Publicado: (2018)

Identifying and revealing different brain neural activities of cognitive subtypes in early course schizophrenia
por: Shao, Tiannan, et al.
Publicado: (2022)

Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials
por: Huang, Jing, et al.
Publicado: (2022)

Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex
por: Shao, Tiannan, et al.
Publicado: (2023)

Dietary fiber and probiotics for the treatment of atypical antipsychotic-induced metabolic side effects: study protocol for a randomized, double-blind, placebo-controlled trial
por: Liu, Chenchen, et al.
Publicado: (2021)

Cognitive effects of atypical antipsychotic drugs in first-episode drug-naïve schizophrenic patients
por: Wang, Juan, et al.
Publicado: (2013)

The effects of probiotics plus dietary fiber on antipsychotic-induced weight gain: a randomized clinical trial
por: Huang, Jing, et al.
Publicado: (2022)

Bidirectional Causal Connectivity in the Cortico-Limbic-Cerebellar Circuit Related to Structural Alterations in First-Episode, Drug-Naive Somatization Disorder
por: Li, Ranran, et al.
Publicado: (2018)

Reduced Brain Activity in the Right Putamen as an Early Predictor for Treatment Response in Drug-Naive, First-Episode Schizophrenia
por: Wu, Renrong, et al.
Publicado: (2019)

ACUTE SCHIZOPHRENIC EPISODES—ARE THEY SCHIZOPHRENIC?
por: Singh, Gurmeet, et al.
Publicado: (1981)

Association of Ishii test scores with pneumonia in stable schizophrenic subjects
por: Yang, Qin, et al.
Publicado: (2022)

Effects of sulforaphane on cognitive function in patients with frontal brain damage: study protocol for a randomised controlled trial
por: Liu, Fangkun, et al.
Publicado: (2020)

Co-prescription of aripiprazole on prolactin levels in long-term hospitalized chronic schizophrenic patients with co-morbid type 2 diabetes: A retrospective clinical study
por: Liu, Xuebing, et al.
Publicado: (2023)

Suicidal Behavior and Medication Adherence in Schizophrenic Patients
por: Warriach, Zain I, et al.
Publicado: (2021)

Factors influencing prolactin levels in chronic long-term hospitalized schizophrenic patients with co-morbid type 2 diabetes mellitus
por: Zhu, Junhong, et al.
Publicado: (2022)

Enhanced Connectivity of Thalamo-Cortical Networks in First-Episode, Treatment-Naive Somatization Disorder
por: Zhao, Jin, et al.
Publicado: (2020)

Association of the Synapse-Associated Protein 97 (SAP97) Gene Polymorphism With Neurocognitive Function in Schizophrenic Patients
por: Xu, Xusan, et al.
Publicado: (2018)

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
por: Yin, Ping, et al.
Publicado: (2021)

Cannabis Use and Dependence among French Schizophrenic Inpatients
por: Lejoyeux, Michel, et al.
Publicado: (2014)

Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
por: Yang, Ye, et al.
Publicado: (2022)

Functional Status of Hypothalamic–Pituitary–Thyroid and Hypothalamic–Pituitary–Adrenal Axes in Hospitalized Schizophrenics in Shanghai
por: Zhu, Yuncheng, et al.
Publicado: (2020)

Abnormal Default Mode Network Homogeneity in Treatment-Naive Patients With First-Episode Depression
por: Gao, Yujun, et al.
Publicado: (2018)

Attentional Load Effects on Beta Oscillations in Healthy and Schizophrenic Individuals
por: Ghorashi, Shahab, et al.
Publicado: (2015)

The Experience of Insomnia in Patients With Schizophrenic Disorder: A Qualitative Study
por: Batalla-Martín, David, et al.
Publicado: (2022)

Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?
por: Cheng, Zhang, et al.
Publicado: (2020)

Increased Nucleus Accumbens Connectivity in Resting-State Patients With Drug-Naive, First-Episode Somatization Disorder
por: Ou, Yangpan, et al.
Publicado: (2019)

An Investigation of Factors Increasing the Risk of Aggressive Behavior among Schizophrenic Inpatients
por: Lejoyeux, Michel, et al.
Publicado: (2013)

The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia
por: Peng, Xing-Jie, et al.
Publicado: (2021)

Corrigendum: The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia
por: Peng, Xing-Jie, et al.
Publicado: (2021)

Corrigendum: The association between cognitive deficits and clinical characteristic in first-episode drug naïve patients with schizophrenia
por: Peng, Xing-Jie, et al.
Publicado: (2022)

Minocycline and antipsychotics inhibit inflammatory responses in BV-2 microglia activated by LPS via regulating the MAPKs/ JAK-STAT signaling pathway
por: Long, Yujun, et al.
Publicado: (2023)

Altered Effective Connectivity in Schizophrenic Patients With Auditory Verbal Hallucinations: A Resting-State fMRI Study With Granger Causality Analysis
por: Gao, Jie, et al.
Publicado: (2020)

Large-scale networks underlie cognitive insight differs between untreated adolescents ongoing their first schizophrenic episode and their reference non-schizophrenic mates
por: Ji, Ruofei, et al.
Publicado: (2022)

Impaired Emotional Self-Referential Processing in First-Episode Schizophrenia
por: Zhao, Yanli, et al.
Publicado: (2021)

Social Cognition in Schizophrenic Patients: The Effect of Semantic Content and Emotional Prosody in the Comprehension of Emotional Discourse
por: Brazo, Perrine, et al.
Publicado: (2014)

The Role of Butyric Acid in Treatment Response in Drug-Naïve First Episode Schizophrenia
por: Li, Xue, et al.
Publicado: (2021)

The meaning of pharmacological treatment for schizophrenic patients
por: Vedana, Kelly Graziani Giacchero, et al.
Publicado: (2014)

Successful switching from risperidone to cariprazine in a schizophrenic patient with pronounced functional deficit. Case report
por: Sahlsten Schölin, Johan, et al.
Publicado: (2023)

Risk Factor for Retreatment Episode on Admission Among TB Patients With Schizophrenia
por: Wang, Hai-Rong, et al.
Publicado: (2021)

Family-based case-control study of homotopic connectivity in first-episode, drug-naive schizophrenia at rest
por: Guo, Wenbin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6jdtgsmfgoemup4s98k30uhqjc